HOME >> BIOLOGY >> NEWS
Surprising study reveals how cancer-causing protein activates

cells to see if it activated STAT3. Using this method, Yuan was able to isolate the culprit: Lys685, one of as many as 780 amino acids that are strung together to make the protein.

Yuan corroborated the finding by testing both a normal and mutated version of STAT3 in a mass spectrometer. The machine smashes the protein into amino acids then sequences these building blocks. The work took nearly two years to complete.

Chin said the research provides an important target for drugs in treating breast and prostate cancers that are common in the United States. According to the American Cancer Society, an estimated 217,440 Americans were diagnosed with breast cancer and 230,110 were diagnosed with prostate cancer in 2004.

"Finding a drug to block both tyrosine phosphorylation and lysine acetylation of STAT3 protein should be a more effective cancer treatment," Chin said.

The research team also included Ying-jie Guan, a post-doctoral fellow in the lab, and Devasis Chatterjee, an assistant professor (research) of Medicine at Brown Medical School.


'"/>

Contact: Wendy Lawton
Wendy_Lawton@brown.edu
401-863-1862
Brown University
13-Jan-2005


Page: 1 2

Related biology news :

1. Surprising new species of light-harvesting bacterium discovered in Yellowstone
2. Surprising origin of cells internal highways
3. Surprising airbag hazards among research findings at hearing safety conference
4. Surprising symbiosis: Glassy-winged sharpshooter eats with friends
5. Surprising genetic differences id-ed in southern house mosquito
6. Surprising killer of southeastern salt marshes: Common sea snails
7. Growing lymph vessels with macrophages? Surprisingly, yes!
8. Surprisingly complex behaviors appear to be hard-wired in the primate brain
9. New study warns limited carbon market puts 20 percent of tropical forest at risk
10. Clones on task serve greater good, evolutionary study shows
11. Pollution causes 40 percent of deaths worldwide, study finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2019)... ... October 11, 2019 , ... Advanced Clinical, ... researcher Dr. Pavel Tyan has been appointed Therapeutic Lead for Oncology. Dr. Tyan ... enhancing the already strong scientific and delivery credentials previously offered at Advanced Clinical. ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a ... attendees of the American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit ... 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare professionals from ...
(Date:10/8/2019)... ... 07, 2019 , ... Imaging data sets are generated through ... projection tomography, optical coherence tomography, echocardiogram, light sheet microscopy, MRI and X-ray CT. ... a lot of research groups struggle with transforming these large and sometimes noisy ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New ... M.D., Ph.D., discussed important design factors that currently limit the success of early stage ... of clinical trials, in his talk Dr. Sherley focused on the highly ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... research in the area of high-level X-ray methods using synchrotron-produced X-rays to ... of Improved Pharma, will present “Synchrotron X-Ray Diffraction and Pair Distribution Function ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, ... the development of therapies to treat central nervous system (CNS) disorders, today ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... PhD, RD, to its Scientific Advisory Board. Dr. Holscher is an Assistant Professor ... Division of Nutritional Sciences at the University of Illinois Urbana-Champaign, where she has ...
Breaking Biology Technology:
Cached News: